You Asked! Question 8

Download a PDF version of this You Asked question and answer here.

Q8:  IEP Team states they don’t use the terms “dyslexia”, “dysgraphia” or “dyscalculia” in student’s IEP.  What can I do?

A:  IDEA requires that the IEP Team tailor specially designed instruction to specifically meet the individual needs of the student.  As Specific Learning Disability is an umbrella term, the IEP Team needs to carefully document all areas of deficits.  If the student exhibits characteristics of dyslexia, dysgraphia, or dyscalculia it is important that these areas of need are specified in the IEP.

The U.S. Department of Education (USDOE) encourages States to review their policies, procedures and practices to ensure that they do not prohibit the use of the terms dyslexia, dyscalculia, or dysgraphia in evaluations, eligibility, and IEP documents.  Finally, in ensuring the provision of Free and Appropriate Public Education, USDOE stressed the importance of addressing the unique educational needs of children with specific learning disabilities resulting from dyslexia, dyscalculia, or dysgraphia during IEP meetings and other meetings with parents under IDEA (Source: OSERS Dear Colleague Letter October 23rd, 2015).  To download a complete copy of this letter, click HERE.

In addition, under the California Education Code Section 56334, deficits in phonological processing need to be identified as part of special education eligibility requirements. A deficit in phonological awareness is viewed as the hallmark of reading disability or dyslexia (Source: The Comprehensive Test of Phonological Processing 2nd Edition Examiners Manual by Richard K. Wagner et al. page 37). It is critical that the IEP team note deficits in phonological processing in the IEP in order to determine the individualized intervention for the student.

Please also see California Department of Education’s PowerPoint page 10 that it is okay for school districts to use the term dyslexia.

For more YOU ASKED questions and answers click HERE

Leading Special Education Expert Pete Wright to Empower Parents and Professionals at Napa Conference

Famous Dyslexic, Pete Wright, is coming to California! Don’t miss this Supreme Court Winning Attorney and U.S. Leading Expert on Special Education Law on May 19, 2017 in Yountville, CA.

Pre-registration is Required.

Registration closes Friday, April 28th.

EVENT DETAILS
The Wrightslaw Special Education Law & Advocacy Conference will be held at the Napa Valley Performing Arts Center at Lincoln Theater on Friday, May 19, 2017. Conference hours are 9 a.m. – 5:30 p.m. The cost to attend is $190 for individuals and $235 for professionals. An early bird rate of $165 or $210, respectively, is available until April 21, 2017.

Pre-registration by April 28 is required. An optional boxed lunch will be offered for $15. Each attendee will receive three of Peter Wright’s books, valued at $62.85. Professional attendees will qualify for CLE and/or CEU credit. Register online at http://www.lincolntheater.com.

The conference agenda covers a variety of special education and advocacy topics, including: special needs assessments and evaluations; determining progress vs. regression; age equivalencies; individualized education plans (IEPs); strategies for parents advocating for their special needs child, including developing a long-term game plan and coping with conflict and crisis; and much more. It will answer such questions as:

  • What rights do parents have in a child’s education?
  • Can the school do that?
  • How do I get more Speech, OT services?
  • What can I do for a child who’s fallen behind in Reading / Math?
  • Can the school say they don’t have the money to provide accommodations or resources?
  • Should the school pay for outside evaluations?
  • What is the school required by law to provide a child?
  • Can the school suspend my child for “behavior problems”?
  • How is my child really doing in school?
  • Does a child qualify for mainstreaming or inclusion (and what’s the difference)?
  • Can the school say a child needs medication?